Tristan Hasbargen, PA-C, a physician assistant at Dermatology Associates of Tallahassee in Tallahassee, Florida, discusses the treatment of vitiligo, emphasizing...
Ted Lain, MD, MBA, a board-certified dermatologist at Sanova Dermatology in Austin, Texas, discusses the randomized phase 3 THRIVE-AA1 trial...
Leon Kircik, MD, a board-certified dermatologist at the Icahn School of Medicine at Mount Sinai in New York, New York,...
David Cotter, MD, PhD, a board-certified dermatologist at Las Vegas Dermatology in Las Vegas, Nevada, discusses a patient case of...
Kara Mudd reviews findings from the Phase 3 TRuE-AD3 study evaluating topical ruxolitinib in children aged 2 to <12 years...
James Del Rosso, DO: JCAD March 2026 Issue Highlights
Ted Lain, MD: Long-Term Results of Deuruxolitinib for Alopecia Areata
James Del Rosso, DO: JCAD February 2026 Issue Highlights
Amy McMichael, MD: Eight-Week Outcomes With Deuruxolitinib in Alopecia Areata
James Del Rosso, DO, and David Cotter, MD, PhD: The Use of Gene-Expression Profile Testing for Effective Atopic Dermatitis Treatment
